References
1. Kurt M, Shaikh KA, Peterson L et
al. Impact of contrast echocardiography on evaluation of ventricular
function and clinical management in a large prospective cohort. J Am
Coll Cardiol 2009;53(9):802-810.
2. Hundley WG, Kizilbash AM, Afridi I,
Franco F, Peshock RM, Grayburn PA. Administration of an intravenous
perfluorocarbon contrast agent improves echocardiographic determination
of left ventricular volumes and ejection fraction: comparison with cine
magnetic resonance imaging. J Am Coll Cardiol 1998;32(5):1426-1432.
3. Nanda NC, Kitzman DW, Dittrich HC,
Hall G, Imagent Clinical Investigators G. Imagent improves endocardial
border delineation, inter-reader agreement, and the accuracy of
segmental wall motion assessment. Echocardiography 2003;20(2):151-161.
4. Attaran RR, Ata I, Kudithipudi V,
Foster L, Sorrell VL. Protocol for optimal detection and exclusion of a
patent foramen ovale using transthoracic echocardiography with agitated
saline microbubbles. Echocardiography 2006;23(7):616-622.
5. Dolan MS, Riad K, El-Shafei A et
al. Effect of intravenous contrast for left ventricular opacification
and border definition on sensitivity and specificity of dobutamine
stress echocardiography compared with coronary angiography in
technically difficult patients. Am Heart J 2001;142(5):908-915.
6. Kumar S, Purtell C, Peterson A,
Gibbons P, Khan AM, Heitner SB. Safety profile of ultrasound enhancing
agents in echocardiography. Echocardiography 2019;36(6):1041-1044.
7. Jung PH, Angermann CE. Clinical
benefits of using second generation ultrasound contrast agents in stress
echocardiography. Echocardiography 2003;20 Suppl 1:S11-18.
8. Kusnetzky LL, Khalid A, Khumri TM,
Moe TG, Jones PG, Main ML. Acute mortality in hospitalized patients
undergoing echocardiography with and without an ultrasound contrast
agent: results in 18,671 consecutive studies. J Am Coll Cardiol
2008;51(17):1704-1706.
9. American College of Cardiology
Foundation Appropriate Use Criteria Task F, American Society of E,
American Heart A et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR
2011 Appropriate Use Criteria for Echocardiography. A Report of the
American College of Cardiology Foundation Appropriate Use Criteria Task
Force, American Society of Echocardiography, American Heart Association,
American Society of Nuclear Cardiology, Heart Failure Society of
America, Heart Rhythm Society, Society for Cardiovascular Angiography
and Interventions, Society of Critical Care Medicine, Society of
Cardiovascular Computed Tomography, and Society for Cardiovascular
Magnetic Resonance Endorsed by the American College of Chest Physicians.
J Am Coll Cardiol 2011;57(9):1126-1166.